AUTHORS
Mehri Bagherimohamadipour, PhD, Mahua Dasgupta, PhD2, Jeffrey A Huebner, PhD3, Maryam Imam, B. Pharm, MS4, Amanda M Brandow, DO, MS5, Ashima Singh, PhD, MS6
AFFILIATIONS
1 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
2 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 University of Wisconsin-Madison, Madison, United States
4 Medical College of Wisconsin, Milwaukee, United States
5 Medical College of Wisconsin, Milwaukee, United States
6 Medical College of Wisconsin, Milwaukee, United States
ABSTRACT
Sickle cell disease (SCD) is an inherited blood disorder caused by a point mutation in the β-globin gene of hemoglobin and is associated with substantial morbidity. Routine outpatient care is recommended to manage this chronic condition and may prevent disease exacerbation. Transportation barriers among individuals with SCD can significantly limit access to care which is likely to contribute to worse health outcomes. Our prior work has shown that only ~60% of Medicaid beneficiaries with SCD are aware of non-emergency medical transportation (NEMT) services. However, it is not known if NEMT use is associated with lower emergency department reliance (EDR) among individuals with SCD in Wisconsin. This study aims to determine if there is an association between NEMT use and EDR among Medicaid beneficiaries with SCD in the state. We hypothesized that greater use of NEMT would be associated with less reliance on the emergency department for care.
This is a cross-sectional study leveraging year 2022 data from the Sickle Cell Data Collection program in Wisconsin (SCDC-WI). Individuals were considered to have SCD if they had a confirmatory newborn screening test result or at least three SCD-related encounters over a five-year period. The analytic cohort included Medicaid beneficiaries with SCD who had at least one NEMT claim during 2022. EDR was defined as the ratio of ED visits to sum of ED and outpatient visits. EDR > 0.33 was categorized as high EDR. Emergency department (ED) and outpatient visits were identified using Medicaid place-of-service codes: codes 11, 19, 22, and 49 were classified as outpatient visits, and code 23 as ED visits. We determined the NEMT use rate as the number of NEMT claims per year. NEMT trips occurring on the same day as an ED visit, ED-to-inpatient encounter, or inpatient admission or discharge were excluded from calculation of NEMT utilization rate. Logistic regression was used to determine the association between high EDR and categorized NEMT utilization (1-2, 3-6, and ≥7 trips per enrollment year), adjusting for age category (pediatrics<19 years, transition 19-25 years, adults>25years, based on age as of January 1, 2022) and Medicaid disability status (disability-based enrollment among beneficiaries<65 year).
Among 1376 individuals with SCD enrolled in WI Medicaid during 2016-2022, 189 had at least one NEMT claim (median age of 33 years; interquartile range (IQR), 19-44 years, 59.3% female, 91.5% were on disability plans) during 2022. The median NEMT rate was 6.5 (IQR, 2.0-22.2) trips per enrollment year, and 37.0% of participants had high EDR. Compared with participants who used 1-2 NEMT trips per enrollment year, those with ≥7 trips per enrollment year had significantly lower odds of high EDR (adjusted odds ratio (aOR), 0.470; 95% CI, 0.225-0.980; p-value = 0.044), whereas those with 3-6 trips per enrollment year did not differ significantly. Transition age participants had significantly higher odds of high EDR than pediatric participants (aOR, 6.165, 95% CI, 1.857-20.466; p-value=0.003), whereas adult age and disability status were not significantly associated with high EDR.
These findings suggest NEMT service utilization may improve access to care among individuals with SCD who have transportation barriers, thereby reducing emergency department reliance. Future studies should incorporate additional social and clinical determinants of health especially among those in the transition age group to characterize healthcare utilization patterns and improve health outcomes
DISCLOSURES
Mehri Bagherimohamadipour, PhD: No relevant conflicts of interest to declare.